Search
Search Results
##search.searchResults.foundPlural##
-
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3760PDF: 1407HTML: 8483 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5045PDF: 1287HTML: 2723Cover letter: 173 -
The diagnostic pitfalls of mucormycosis
823PDF: 687HTML: 227 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3264PDF: 563HTML: 630 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1264PDF: 869Suppl. Files: 429HTML: 218 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2007PDF: 1004HTML: 15640COVER LETTER: 163 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4236PDF: 1447HTML: 1531Untitled: 209 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3459PDF: 1442HTML: 4277CoverLetter: 167Figure1: 175 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3119PDF: 1015HTML: 411 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2293PDF: 880HTML: 480 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3169PDF: 1485HTML: 392 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
898PDF: 485HTML: 170 -
Postpandemic influenza A/H1N1pdm09 is still causing severe perinatal complications
1307PDF: 956HTML: 1994Cover letter: 182 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
1982PDF: 900HTML: 278 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
7807PDF: 3166HTML: 1171 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1519PDF: 546HTML: 213 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1442PDF: 688HTML: 214 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
760PDF: 658HTML: 291 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1200PDF: 899HTML: 82 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1080PDF: 872HTML: 280 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2332PDF: 1170HTML: 3583Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 394 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3516PDF: 1077HTML: 23314







